ResearcherID - CLICK HERE Scientific Journal Impact Factor (SJIF-2020) - CLICK HERE

TITLE:

COMPARISON OF PRE-OPERATIVE AND POST-OPERATIVE JAUNDICE LEVEL USING PTCD REDUCTION TECHNIQUE FOR AE

AUTHORS:

Muhammad Ali, Fan Hai Ning, Yang Dan Cai Rang, Waseem Sami Malik, Raees Ahmad, Muhammad Shoaib Tahir

ABSTRACT:

Aim: To assess the pre and post-operative jaundice level clinical efficacy and safety of an advanced percutaneous trans-hepatic cholangio-drainage to organize the alveolar echinococcosis patients and to prevent further liver damage and improve quality of life. Sustain bile flow to avoid jaundice and get ready patient for surgery. Method: The data of 47 patients who underwent PTCD to minimize the jaundice level for surgery. After decrease yellow discoloration, the patients go through surgery for the AE lesion. The patients were examined for instant adverse events together with hemorrhage, perforation, pancreatitis, and cholangitis. We used paired t-test for statics analysis of data, during the two-year follow-up, they were observed for the reappearance of jaundice and AE. Results: Bilirubin levels considerable decline in 47 patients significantly (P < 0.05). Common bile duct mild bleeding and infection occurred in patient. No severe adverse measures, having pancreatitis or perforation of the gastrointestinal or common bile duct occurred. Conclusion: Sequential PTCD is safe and effective for the patient AE with jaundice. This method is responsible for low-risk quantity, fast to attain the preferred effect related complications produced by less active and to get better the patient liver function, recover the patient’s quality of life has accomplished good clinical effect. Keywords: Alveolar Echinococcosis (AE), Hydatid Alveolar Echinococcosis (HAE), Percutaneous trans-hepatic cholangio-drainage (PTCD), Alanine aminotransferase (ALT), Total bilirubin (TB), Albumin (ALB), White Blood Cell (WBC) and Red Blood Cell (RBC).

Top
  • Follows us on
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.